J. Sven D. Mieog

Leiden University — Netherlands

Medicine · Health Sciences

46h-index8.6kcitations318works6.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(163), Pancreatitis Pathology and Treatment(57), Hepatocellular Carcinoma Treatment and Prognosis(39), Cancer Genomics and Diagnostics(39), Nanoplatforms for cancer theranostics(38)

Publications312 total

Staging laparoscopy to detect occult metastases in localized pancreatic cancer: global survey among nine international societies
HPB·2025Open Access
Minimally Invasive versus Open Pancreatoduodenectomy for Resectable Neoplasms
NEJM Evidence·2025· 9 cited
Both skeletal muscle index and muscle attenuation are associated with frailty in preoperative older patients with pancreatic cancer
Clinical Nutrition·2025Open Access
Nationwide outcomes of 1000 robotic pancreatoduodenectomies across the four phases of the learning curve
British journal of surgery·2025· 2 citedOpen Access
Endoscopic versus surgical gastroenterostomy for palliation of malignant gastric outlet obstruction (ENDURO): a randomised controlled trial
˜The œLancet. Gastroenterology & hepatology·2025· 5 cited
The effectiveness of adding Braun anastomosis to standard Child reconstruction to reduce delayed gastric emptying after pancreatoduodenectomy (REMBRANDT): study protocol for a multicentre randomised-controlled trial
Trials·2025Open Access
Revolutionizing Solid Tumor Surgery with Fibroblast Activation Protein (FAP)-Targeted Imaging Probes for a Fluorescence-Guided Surgery of Pancreatic Cancer
Bioconjugate Chemistry·2025
Influence of socioeconomic position on surgical outcomes after resection of colorectal liver metastases
European Journal of Surgical Oncology·2025Open Access
Short- and long-term outcomes after venous resection during left-sided and total pancreatic resection: a nationwide cohort study
HPB·2025Open Access
Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial
The Lancet Oncology·2025· 18 cited
Preoperative chemotherapy reduces the accumulation of indocyanine green around colorectal liver metastases for use in fluorescence-guided surgery
Surgical Endoscopy·2025· 2 citedOpen Access
Correction: Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers
EJNMMI Research·2025Open Access
Selection for local treatment and outcomes of surgical resection in patients with synchronous colorectal liver metastases: A nationwide population-based study
European Journal of Surgical Oncology·2025· 1 citedOpen Access
Surgical Complications in Patients with (borderline) Resectable Pancreatic Cancer after Neoadjuvant Therapy in the PREOPANC-2 Randomized Controlled Trial
Annals of Surgery·2025Open Access
Time-varying impact of established prognostic factors in resected pancreatic ductal adenocarcinoma
JNCI Journal of the National Cancer Institute·2025
Oncological outcome after robot-assisted <i>versus</i> open pancreatoduodenectomy for upfront resectable cancer in the pancreatic head: a nationwide cohort analysis
British journal of surgery·2025Open Access
Cost-effectiveness of [18F]FDG PET/CT in follow-up after thermal ablation in patients with colorectal liver metastases in the Dutch healthcare setting
European Journal of Radiology·2025Open Access
Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers
EJNMMI Research·2025· 1 citedOpen Access
Long-term Local Control Following CEA-targeted Fluorescence-guided Surgery in Patients With Locally Advanced and Recurrent Rectal Cancer
Molecular Imaging and Biology·2025· 1 citedOpen Access
Evaluation of tumor targets selected from public genomic databases for imaging of pancreatic ductal adenocarcinoma
Scientific Reports·2025· 4 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Alexander L. Vahrmeijer(32), Cornelis J.�H. van de Velde(17), Merlijn Hutteman(14), Joost R. van der Vorst(14), Bert A. Bonsing(13), Clemens W.G.M. Löwik(12), John V. Frangioni(12), Marc G. Besselink(12), Rutger‐Jan Swijnenburg(12), Peter J.K. Kuppen(10), Olivier R. Busch(8), Gerrit‐Jan Liefers(8), Hein Putter(8), Ignace H. J. T. de Hingh(7), Bas Groot Koerkamp(7), Hjalmar C. van Santvoort(7), Sebastiaan Festen(6), Gijs A. Patijn(6), Martijn W.J. Stommel(6), Joost M. Klaase(6)